The potential DPP-4 inhibitors from Xiao-Ke-An improve the glucolipid metabolism via the activation of AKT/GSK-3β pathway
Shumin Jiang, Xueli Wu, Yi Wang, Jingtao Zou, Xiaoping Zhao
Topics & Concepts
Protein kinase BEndocrinologyGSK-3ChemistryInternal medicinePhosphorylationGlycogen synthaseDipeptidyl peptidaseIncretinProtein kinase AInsulin resistanceGinsenosideInsulinPharmacologyBiochemistryEnzymeBiologyDiabetes mellitusType 2 diabetesMedicineAlternative medicinePathologyGinsengDiabetes Treatment and ManagementPeptidase Inhibition and AnalysisMetabolism, Diabetes, and Cancer